In vivo experiments on wild-type mice have shown that IL-6 is significantly augmented at the colonic tumor environment, and the growth of colon tumors was suppressed when the mice were treated with antibodies against IL6R [61]. This evidence concerns the gene IL6 and colonic neoplasm.